Blood Research

Cited by CrossRef (11)

  1. Thejus T. Jayakrishnan, Veli Bakalov, Yazan Samhouri, Rodney E. Wegner, Santhosh Sadashiv. Outcomes of Treatment for HIV-Infected Lymphoma Patients: A National Cancer Database (NCDB) Analysis. Clinical Lymphoma Myeloma and Leukemia 2020;20:e864
    https://doi.org/10.1016/j.clml.2020.06.003
  2. Chaoyu Wang, Jun Liu, Haike Lei, Yu Li, Jian Wu, Bingling Guo, Renzhi Hu, Tingting Liu, Jing Wu, Yao Ding, Chongling Hu, Shunsi Liang, Chunyan Xiao, Xiping Liang, Dehong Huang, Tao Yang, Wenjun Zhang, Zailin Yang, Jieping Li, Yingyu Nan, Qiying Li, Ying Xiang, Zhenhua Li, Yongzhong Wu, Yao Liu. Clinical characteristics and outcomes of newly diagnosed patients with HIV‐associated aggressive B‐cell NHL in China. J Cellular Molecular Medi 2022;26:5067
    https://doi.org/10.1111/jcmm.17534
  3. Reema Singh, Jyotsna Kapoor, Nisha Panwar, Sujay Rainchwar, Pritish Chandra Patra, Rohan Halder, Rayaz Ahmed, Narendra Agrawal, Dinesh Bhurani. HIV Associated Lymphomas: A Double-Edged Sword. Indian J Hematol Blood Transfus 2024;40:146
    https://doi.org/10.1007/s12288-023-01636-3
  4. Chaoyu Wang, Jun Liu, Haike Lei, Yu Li, Jian Wu, Bingling Guo, Renzhi Hu, Tingting Liu, Jing Wu, Yao Ding, Chongling Hu, Shunsi Liang, Chunyan Xiao, Xiping Liang, Dehong Huang, Tao Yang, Wenjun Zhang, Zailin Yang, Jieping Li, Yingyu Nan, Qiying Li, Ying Xiang, Yongzhong Wu, Yao Liu. Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Human Immunodeficiency Virus-Associated Lymphoma Administered Highly Active Antiretroviral Therapy: Central and Western China Aids Lymphoma League 001 Study (cw-CALL 001). SSRN Journal 2022
    https://doi.org/10.2139/ssrn.4007459
  5. Chaoyu Wang, Yan Wu, Jun Liu, Haiyan Min, Yunhong Huang, Guo Wei, Wei Zhang, Min Wang, Xiaoqiong Tang, Hui Zhou, Yaokai Chen, Yao Liu. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study). Front. Immunol. 2023;14
    https://doi.org/10.3389/fimmu.2023.1153790
  6. Hirotaka Mori, Masahiko Fukatsu, Hiroshi Ohkawara, Yuka Oka, Yuki Kataoka, Shunsuke Taito, Takayuki Ikezoe. Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review. Int J Hematol 2021;114:639
    https://doi.org/10.1007/s12185-021-03211-w
  7. Xue Chen, Lin Jia, Xiuqun Zhang, Tong Zhang, Yulin Zhang. One arrow for two targets: potential co-treatment regimens for lymphoma and HIV. Blood Reviews 2022;55:100965
    https://doi.org/10.1016/j.blre.2022.100965
  8. Nadine Rapiti, Nasheeta Peer, Nada Abdelatif, Pamela Rapiti, Yunus Moosa. HIV‐associated plasmablastic lymphoma: A single‐centre 12‐year experience in Kwa‐Zulu Natal, South Africa. HIV Medicine 2022;23:837
    https://doi.org/10.1111/hiv.13266
  9. Chaoyu Wang, Jun Liu, Yao Liu. Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies. Front. Oncol. 2022;11
    https://doi.org/10.3389/fonc.2021.798008
  10. Yimam Getaneh, Fentabil Getnet, Abdur Rashid, Li Kang, Qingfei Chu, Sisi Li, Feng Yi, Yiming Shao. The spectrum of opportunistic infections and malignancies among women on antiretroviral therapy in Ethiopia. Emerging Microbes & Infections 2023;12
    https://doi.org/10.1080/22221751.2023.2271065
  11. Manju Sengar, Hasmukh Jain, Tanuja Shet, Epari Sridhar, Vikram Gota, Venkatesh Rangarajan, Siddhartha S. Laskar, Aruna Alahari, Jayashree Thorat, Archi Agarwal, Neha Sharma, Himanshi Gupta, Sadhana Kannan, Shikhar Kumar, Lingaraj Nayak, Hari Menon, Sumeet Gujral, Bhausaheb Bagal. Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)‐associated lymphomas. Br J Haematol 2023;200:429
    https://doi.org/10.1111/bjh.18532
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd